FDA, EMEA To Compare Regulatory Approaches Used For NMEs
This article was originally published in The Tan Sheet
Executive Summary
FDA and the European Medicines Evaluation Agency will conduct a joint assessment of the approaches used by the two agencies in the 1998 cohort of new molecular entity reviews.